Sujal Shah - Jan 25, 2022 Form 4 Insider Report for CymaBay Therapeutics, Inc. (CBAY)

Role
Chief Executive Officer, Director
Signature
/s/ Sujal Shah
Stock symbol
CBAY
Transactions as of
Jan 25, 2022
Transactions value $
$0
Form type
4
Date filed
1/27/2022, 03:55 PM
Next filing
Jun 7, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CBAY Employee Stock Option (right to buy) Award $0 +650K $0.00 650K Jan 25, 2022 Common Stock 650K $2.94 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests as to 1/48 of the underlying shares monthly from January 1, 2022.